Considering the pps has been halved, since it's high of $3.10, that's a good thing. Without that major catalyst to reverse momentum GNBT will perform like every other small biotech. When the news stop, the pps goes down. Until the company delivers, there's only faith and hope. That may be enough to keep some from selling, but faith and hope won't attract new investors.

I think I said several times that in this way NuGenerex is the same as OlGenerex. Unless there is news of non-toxic funding, buyouts, spin-offs, partnerships, or uplisting, the price will slowly drift down.

Maybe the 10-K will be out on Friday and show some real earnings. The 1:20 dividend and NGIO shares were delivered as promised. That's enough for me to hold and even to buy strategically, at the right price.